Astrazeneca Says Klygefa Recommended For EU Approval To Treat Adults With Generalized Myasthenia Gravis

By Reuters News

- AstraZeneca PLC AZN.L:

  • ASTRAZENECA: KLYGEFA (GEFURULIMAB) RECOMMENDED FOR APPROVAL IN EU BY CHMP FOR TREATMENT OF ADULTS WITH GENERALISED MYASTHENIA GRAVIS (GMG)

Source text: [ID:]

Further company coverage: AZN.L

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk